ERBB2 and neoplasm: In some cases of IHC, when ≤10% of tumor cells show strong, circular membrane staining, which is heterogeneous and uneven, discohesive in the tumor, these cases may be considered equivocal HER2 2+ and another sample needs to be provided for (re)testing due to pronounced tumor heterogeneity.